Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Verona Pharma plc | General Counsel | Ordinary Shares | 1.62M | $32.5M | $20.00 | Feb 1, 2024 | Direct |
Verona Pharma plc | General Counsel | Ordinary Shares | 1.18M | $23.5M | $20.00 | Feb 1, 2024 | By Trust |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VRNA | Verona Pharma plc | Feb 1, 2024 | 3 | -$237K | 4 | Feb 5, 2024 | General Counsel |
VRNA | Verona Pharma plc | Nov 1, 2023 | 3 | -$303K | 4 | Nov 3, 2023 | General Counsel |
VRNA | Verona Pharma plc | Oct 20, 2023 | 1 | $0 | 4 | Oct 24, 2023 | General Counsel |
VRNA | Verona Pharma plc | Aug 3, 2023 | 5 | -$122K | 4 | Aug 7, 2023 | General Counsel |
VRNA | Verona Pharma plc | Aug 1, 2023 | 2 | -$83.4K | 4 | Aug 3, 2023 | General Counsel |
VRNA | Verona Pharma plc | May 1, 2023 | 2 | $0 | 4/A | May 11, 2023 | General Counsel |
VRNA | Verona Pharma plc | Jan 20, 2023 | 7 | -$394K | 4 | Feb 3, 2023 | General Counsel |
VRNA | Verona Pharma plc | Sep 26, 2022 | 1 | $0 | 4 | Sep 28, 2022 | General Counsel |
VRNA | Verona Pharma plc | Aug 1, 2022 | 1 | -$53.7K | 4 | Aug 3, 2022 | General Counsel |
VRNA | Verona Pharma plc | May 1, 2022 | 1 | -$41.7K | 4 | May 3, 2022 | General Counsel |
VRNA | Verona Pharma plc | Feb 1, 2022 | 1 | -$62K | 4 | Feb 3, 2022 | General Counsel |
VRNA | Verona Pharma plc | Nov 21, 2021 | 11 | -$646K | 4 | Dec 27, 2022 | General Counsel |
VRNA | Verona Pharma plc | Nov 1, 2021 | 1 | -$51.1K | 4 | Nov 3, 2021 | General Counsel |
VRNA | Verona Pharma plc | Aug 1, 2021 | 3 | -$251K | 4 | Aug 3, 2021 | General Counsel |